Related Experiment Video
Updated: Aug 14, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
[Treatment of liver and lung metastases from colorectal cancer]
Flemming Burcharth1, Benny Vittrup Jensen
1Amtssygehuset i Herlev, Kirurgisk-gastroenterologisk Afdeling. flbu@herlevhosp.kbhamt.dk
Abstract:
Metastases from colorectal cancer are most often confined to the liver or lungs, in which 20-25% may be resected with curative intent. Without treatment, no patients are alive after four years, whereas 30% are alive four years after radical resection. Early use of chemotherapy increases survival, and about 20% of patients may thus become suited for local therapy. After the primary operation, surveillance is recommended, with measurement of carcinoembryonal antigene every 3-6 months for 3 years, then every 6-12 months from years 3 to 5, plus ultrasound or CT scan every 6 months for 3 years, then yearly for up to 5 years.
More Related Videos
04:22Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017